3801Surveillance de la santé publique dans le contexte de la COVID-19 : orientations provisoires, 14 février 2022Technical Documents · March 11, 2022
3802Emergency in Ukraine: external situation report #2, published 11 March 2022: reporting period: 4–11 March 2022Technical Documents · March 11, 2022
3803Vigilancia de salud pública en relación con la COVID-19: orientaciones provisionales, 14 de febrero de 2022Technical Documents · March 11, 2022
3804Western Pacific regional framework to end TB: 2021-2030: brief summaryTechnical Documents · March 10, 2022
3805Plataforma clínica mundial de la OMS sobre la COVID-19: formulario de base de registro de casos, 8 de abril de 2020, revisada el 13 de julio de 2020, revisada el 29 de noviembre de 2021Technical Documents · March 10, 2022
3806Provision of immunization services to refugees: guidance for host countries in the context of mass population movement from Ukraine. March 2022.Technical Documents · March 9, 2022
3807The Mekong malaria elimination programme: accelerating malaria elimination in the Greater MekongTechnical Documents · March 9, 2022
3808One hundred million cases in one hundred weeks: working towards better COVID-19 outcomes in the WHO European RegionTechnical Documents · March 9, 2022
3809Expert Group Consultation on supporting the infant and young child nutrition through improving feeding practices and the food environment, WHO South-East Asia Region: 20-21 October 2021Technical Documents · March 9, 2022
3810Use of SARS-CoV-2 antigen-detection rapid diagnostic tests for COVID-19 self-testing: interim guidance, 9 March 2022: web annex A: GRADE table: should COVID-19 self-testing, using SARS-CoV-2 Ag-RDTs, be offered as an additional approach?Technical Documents · March 8, 2022
3811Use of SARS-CoV-2 antigen-detection rapid diagnostic tests for COVID-19 self-testing: interim guidance, 9 March 2022: web annex F: declarations of interest for the Guideline Development Group, observers and peer reviewersTechnical Documents · March 8, 2022
3812Use of SARS-CoV-2 antigen-detection rapid diagnostic tests for COVID-19 self-testing: interim guidance, 9 March 2022Technical Documents · March 8, 2022
3813Use of SARS-CoV-2 antigen-detection rapid diagnostic tests for COVID-19 self-testing: interim guidance, 9 March 2022: web annex D: global survey on COVID-19 self-testing using SARS-CoV-2 Ag-RDTsTechnical Documents · March 8, 2022
3814Use of SARS-CoV-2 antigen-detection rapid diagnostic tests for COVID-19 self-testing: interim guidance, 9 March 2022: web annex B: COVID-19 self-testing using antigen rapid diagnostic tests: feasibility evaluation among health-care workers and general population in Malawi and ZimbabweTechnical Documents · March 8, 2022
3815Recomendaciones provisionales sobre el uso de la vacuna mRNA-1273 de Moderna contra la COVID-19: orientaciones provisionales, versión inicial: 25 de enero de 2021, primera actualización: 15 de junio de 2021, segunda actualización: 19 de noviembre de 2021, actualización más reciente: 23 de febrero de 2022Technical Documents · March 8, 2022
3816COVID-19 weekly epidemiological update, edition 82, 8 March 2022Technical Documents · March 8, 2022
3817Use of SARS-CoV-2 antigen-detection rapid diagnostic tests for COVID-19 self-testing: interim guidance, 9 March 2022: web annex E: evidence to decision making table: should COVID-19 self-testing, using Ag-RDTs, be offered as an additional testing approach?Technical Documents · March 8, 2022
3818Use of SARS-CoV-2 antigen-detection rapid diagnostic tests for COVID-19 self-testing: interim guidance, 9 March 2022: web annex C: multi-country study of values and preferences on COVID-19 self-testing using SARS-CoV-2 Ag-RDTsTechnical Documents · March 8, 2022
3819Infection prevention and control in the context of coronavirus disease (COVID-19): a living guideline, 7 March 2022Technical Documents · March 7, 2022
3820Orientaciones evolutivas para el manejo clínico de la COVID-19: orientaciones evolutivas, 23 de noviembre de 2021Technical Documents · March 4, 2022